MUMPS
MCID: MMP001
MIFTS: 58

Mumps (MUMPS) malady

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Mumps

About this section

Summaries for Mumps

About this section
MedlinePlus:38 Mumps is an illness caused by the mumps virus. it starts with fever headache muscle aches tiredness loss of appetite after that, the salivary glands under the ears or jaw become swollen and tender. the swelling can be on one or both sides of the face. symptoms last 7 to 10 days. serious complications are rare. you can catch mumps by being with another person who has it. there is no treatment for mumps, but the measles-mumps-rubella (mmr) vaccine can prevent it. before the routine vaccination program in the united states, mumps was a common illness in infants, children and young adults. now it is a rare disease in the u.s. centers for disease control and prevention

MalaCards based summary: Mumps is related to hepatitis and newcastle disease, and has symptoms including fever, pruritus and fever. An important gene associated with Mumps is STAT2 (Signal Transducer And Activator Of Transcription 2), and among its related pathways are Type III Interferon Signaling Pathways and CXCR4-mediated signaling events. Affiliated tissues include salivary gl, salivary gland and brain, and related mouse phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and liver/biliary system.

CDC:2 Mumps is a contagious disease caused by a virus. It typically starts with a few days of fever, headache, muscle aches, tiredness, and loss of appetite, followed by swollen salivary glands. You can protect yourself and your family against mumps with vaccination.

Disease Ontology:11 A viral infectious disease that results in inflammation located in salivary gland, has material basis in Mumps virus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face.

Wikipedia:71 Mumps, also known as epidemic parotitis, is a viral disease caused by the mumps virus. Initial signs and... more...

Related Diseases for Mumps

About this section

Diseases in the Mumps family:

Congenital Mumps

Diseases related to Mumps via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 310)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis29.7HLA-DRB1, IFNG, IL10, IL2, TNF
2newcastle disease29.1CD40LG, IL2, TNF
3paralytic poliomyelitis29.1IFNG, IL2
4autistic disorder29.0HLA-DRB1, IFNG, IL10, TNF
5chorioretinitis28.9CD40LG, HLA-DRB1, IFNG, IL10, TNF
6congenital mumps11.9
7primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection11.8
8measles11.4
9rubella11.4
10acute disseminated encephalomyelitis11.2
11endotheliitis11.0
12acute hemorrhagic leukoencephalitis11.0
13testicular microlithiasis10.7
14infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.7
15male infertility10.7
16salivary gland disease10.7
17immune-mediated encephalomyelitis10.7
18postinfectious encephalomyelitis10.7
19orchitis10.3
20meningitis10.3
21pyridoxal 5'-phosphate-dependent epilepsy10.2IL10, TNF
22aseptic meningitis10.2
23trachoma10.2CD40LG, STAT1, STAT2
24bilateral parasagittal parieto-occipital polymicrogyria10.2HLA-DPB1, HLA-DRB1, TNF
25tubular renal disease-cardiomyopathy syndrome10.2IL10, TNF
26human immunodeficiency virus infectious disease10.2CD40LG, HLA-DRB1, TNF
27skin benign neoplasm10.2IL10, STAT1, STAT2
28parotitis10.2
29maturity-onset diabetes of the young10.1CD40LG, IL10
30stiff-person syndrome10.1CD40LG, HLA-DRB1, IFNG
31steatitis10.1IL2, TNF
32choreatic disease10.1CD40LG, HLA-DRB1, TNF
33oral cavity cancer10.1CD40LG, IFNG, TNF
34acute cholangitis10.1CD40LG, HLA-DRB1, TNF
35myofibroma10.1HLA-DRB1, IFNG, IL10
36autosomal recessive pericentral pigmentary retinopathy10.1IL10RB, TNF
37stocco dos santos syndrome10.1IFNG, TNF
38bacterial meningitis10.1CD40LG, HLA-DRB1, TNF
39low anorectal malformation10.1HLA-DRB1, IL10, TNF
40peripheral artery disease10.1HLA-DRB1, IL10, TNF
41osteodysplasty precocious of danks mayne and kozlowski10.1IFNG, IL10, TNF
42parkinson disease 1110.1IFNG, IL10, TNF
43chronic gonorrhea of cervix10.1IFNG, IL10, STAT1
44neurotic disorder10.1IFNG, IL10, TNF
45reproductive system disease10.1CD40LG, HLA-DRB1, IL10
46senile reticular retinal degeneration10.1IFNG, IL10, TNF
47pulpitis10.1IFNG, IL10, TNF
48ectodermal dysplasia bartalos type10.1IFNG, IL10, TNF
49follicular adenoma10.1IFNG, IL10, TNF
50distal trisomy 14q10.1HLA-DPB1, HLA-DRB1, IFNG, TNF

Graphical network of the top 20 diseases related to Mumps:



Diseases related to mumps

Symptoms & Phenotypes for Mumps

About this section

Symptoms:

 11 (show all 6)
  • fever
  • headache
  • muscle aches
  • tiredness
  • loss of appetite
  • swollen

UMLS symptoms related to Mumps:


fever, pruritus

GenomeRNAi Phenotypes related to Mumps according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00250-A-16.7CD40LG, IL10, IL2, IL2RA, STAT1, TNF

MGI Mouse Phenotypes related to Mumps according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.7IFNG, IL10, IL10RB, IL12RB2, IL2, STAT1
2MP:00053858.5CD40LG, CD46, IFNG, IL10, IL12RB2, IL2
3MP:00053818.4IFNG, IL10, IL10RB, IL12RB2, IL2, IL2RA
4MP:00020068.2IFNAR2, IFNG, IL10, IL12RB2, IL2, STAT1
5MP:00053798.1CD40LG, IFNG, IL10, IL10RB, IL12RB2, IL2
6MP:00053917.8CD46, IFNG, IL10, IL2, IL2RA, STAT1
7MP:00107686.9CD40LG, IFNAR2, IFNG, IL10, IL10RB, IL2
8MP:00053976.7CD40LG, IFNAR2, IFNG, IL10, IL10RB, IL12RB2
9MP:00053876.7CD40LG, IFNAR2, IFNG, IL10, IL10RB, IL12RB2

Drugs & Therapeutics for Mumps

About this section

Drugs for Mumps (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 65)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1AntibodiesPhase 4, Phase 2, Phase 16394
2VaccinesPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 16611
3ImmunoglobulinsPhase 4, Phase 2, Phase 16394
4Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2465
5Pharmaceutical SolutionsPhase 4, Phase 3, Phase 28192
6Liver ExtractsPhase 44067
7
Aluminum hydroxideapprovedPhase 3, Phase 221021645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
8
Tetracyclineapproved, vet_approvedPhase 3, Phase 210560-54-85353990
Synonyms:
(-)-Tetracycline
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
87128_FLUKA
87128_SIGMA
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Abramycin
Abricycline
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
BPBio1_000242
BSPBio_000220
BSPBio_001950
Bio-tetra
Biocycline
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
C06570
CHEBI:27902
CHEMBL1440
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
Cefracycline
Cefracycline suspension
Centet (base)
Ciclibion
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
HSDB 3188
Hostacyclin
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
LS-187078
LS-93869
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin
Liquamycin (Veterinary)
 
Liquamycin, veterinary
MLS000069728
Medocycline
Mericycline
Micycline
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
NINDS_000827
NSC 108579
NSC108579
Neocycline
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (VAN)
Polycycline (antibiotic)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
SK-Tetracycline
SMR000058220
SPBio_001457
SPBio_002159
STOCK1N-42738
Sanclomycine
Solvocin
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
Spectrum_001034
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetra-Co
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetracycl
Tetracyclin
Tetracycline & VRC3375
Tetracycline (JAN/USP/INN)
Tetracycline (internal use)
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracycline [USAN:INN:BAN:JAN]
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
Tétracycline
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
component of Tetrastatin
methyl-1,11-dioxo-2-naphthacenecarboxamide
nchembio.273-comp1
nchembio.289-comp1
tetracycline
9Anti-Bacterial AgentsPhase 3, Phase 211226
10Anti-Infective AgentsPhase 3, Phase 222062
11PENTAPhase 3, Phase 2109
12
LactitolPhase 3, Phase 2336585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
13
AltretamineapprovedPhase 265645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
14
Daclizumabapproved, investigationalPhase 298152923-56-3
Synonyms:
 
Dacliximab
Daclizumab beta
15
ObinutuzumabapprovedPhase 2, Phase 1105949142-50-1
Synonyms:
 
Afutuzumab
16
Prednisoloneapproved, vet_approvedPhase 2119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
17
Methylprednisoloneapproved, vet_approvedPhase 2119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
18
Mycophenolic acidapprovedPhase 295224280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
19
Mycophenolate mofetilapproved, investigationalPhase 2952128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
20
Prednisoneapproved, vet_approvedPhase 2139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
21Peripheral Nervous System AgentsPhase 223689
22Antibodies, MonoclonalPhase 24039
23Immunoglobulin GPhase 2275
24Fibrinolytic AgentsPhase 22388
25AnticoagulantsPhase 22623
26Immunosuppressive AgentsPhase 213086
27Interleukin-2Phase 2571
28Prednisolone hemisuccinatePhase 21193
29Prednisolone acetatePhase 21193
30Protective AgentsPhase 27443
31Neuroprotective AgentsPhase 21716
32Prednisolone phosphatePhase 21193
33Methylprednisolone HemisuccinatePhase 21193
34Antineoplastic Agents, HormonalPhase 25592
35Anti-Inflammatory AgentsPhase 210729
36AntiemeticsPhase 24022
37Methylprednisolone acetatePhase 21193
38Autonomic AgentsPhase 210150
39Antibiotics, AntitubercularPhase 27180
40Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 213168
41Gastrointestinal AgentsPhase 28402
42HormonesPhase 214415
43Hormone AntagonistsPhase 213180
44glucocorticoidsPhase 25103
45Immunoglobulins, IntravenousPhase 1333
46Rho(D) Immune GlobulinPhase 1326
47gamma-GlobulinsPhase 1326
48
Acetylcholineapproved80551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
49
Azathioprineapproved177446-86-62265
Synonyms:
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC-4230
AC1L1DAL
AC1Q3Z1F
AI-981/34845012
AI3-50290
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
Azathioprine (JP15/USP/INN)
Azathioprine Sodium
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57-322
BW 57322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
CHEBI:2948
CHEMBL1542
CID2265
CPD000427366
Ccucol
ChemDiv1_002659
Cytostatics
D00238
DB00993
DivK1c_000586
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
HMS1920E17
 
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imuran (tn)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
LS-123
Lopac-A-4638
Lopac0_000027
MLS001049307
Methylnitroimidazolylmercaptopurine
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC-39084
NSC39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
Prestwick_41
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
SPBio_000255
SPBio_001987
SPECTRUM1500133
STK831906
STOCK1S-20293
STOCK1S-27186
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
Spectrum_000064
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
[Methyl(nitroimidazolyl)mercaptopurine]
azathioprine
azatiopr in
cMAP_000046
50
Adalimumabapproved494331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region

Interventional clinical trials:

(show top 50)    (show all 131)
idNameStatusNCT IDPhase
1The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineUnknown statusNCT02153866Phase 4
2Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
3Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisCompletedNCT00731965Phase 4
4Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose PresentationsCompletedNCT01777529Phase 4
5Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819Phase 4
6Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
7Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) VaccineCompletedNCT03160820Phase 4
8MMR Vaccination Among HIV-infected AdultsCompletedNCT02724852Phase 4
9Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)CompletedNCT00326183Phase 4
10Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
11Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
12MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
13Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenCompletedNCT02253407Phase 4
14Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
15Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
16Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella VaccineRecruitingNCT02880865Phase 4
17Homeopathic Vaccine TrialRecruitingNCT02825368Phase 4
18Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 4
19Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRActive, not recruitingNCT02325310Phase 4
20Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
21Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy InfantsUnknown statusNCT01763268Phase 2, Phase 3
22A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)CompletedNCT00092391Phase 3
23Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
24Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
25Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderCompletedNCT02058563Phase 3
26Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3
27Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
28Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
29Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.CompletedNCT01991899Phase 3
30Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3
31Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
32Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
33Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3
34Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
35Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
36Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
37ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
38Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
39Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3
40ProQuad® rHA SafetyCompletedNCT00560755Phase 3
41Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered ConcomitantlyCompletedNCT00432042Phase 3
42Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
43Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3
44Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
45A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
46Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
47ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3
48Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous RouteCompletedNCT00432523Phase 3
49Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHACompletedNCT00566527Phase 3
50Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 YearsCompletedNCT00871117Phase 3

Search NIH Clinical Center for Mumps


Cochrane evidence based reviews: mumps

Genetic Tests for Mumps

About this section

Anatomical Context for Mumps

About this section

MalaCards organs/tissues related to Mumps:

36
Salivary gland, Brain, Testes, B cells, T cells, Endothelial, Skin

FMA organs/tissues related to Mumps:

17
Salivary gl

Publications for Mumps

About this section

Articles related to Mumps:

(show top 50)    (show all 793)
idTitleAuthorsYear
1
Complete Genome Sequence of Mumps Virus Isolated from Karnataka State, India. (28082488)
2017
2
Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015. (28085897)
2017
3
Heat shock protein 90 ensures efficient mumps virus replication by assisting with viral polymerase complex formation. (28053100)
2017
4
Mumps makes a comeback: What nurses need to know. (28027128)
2017
5
Pancreatic pseudocyst after measles, mumps, and rubella vaccination. (28082255)
2017
6
Mumps transmission in social networks: a cohort study. (28068914)
2017
7
How will the MMR universal mass vaccination change the epidemiologic pattern of mumps? A 2012 Italian serosurvey. (27156389)
2016
8
Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015-2016. (27467572)
2016
9
Waning immunity against mumps in vaccinated young adults, France 2013. (26987576)
2016
10
Mumps virus induces innate immune responses in mouse ovarian granulosa cells through the activation of Toll-like receptor 2 and retinoic acid-inducible gene I. (27477784)
2016
11
Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants. (27822935)
2016
12
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis. (27163657)
2016
13
Mumps Presenting as a Parotid Abscess. (27159869)
2016
14
Mumps Virus Induces Protein-Kinase-R-Dependent Stress Granules, Partly Suppressing Type III Interferon Production. (27560627)
2016
15
Recombinant mumps viruses expressing the batMuV fusion glycoprotein are highly fusion-active and neurovirulent. (27590163)
2016
16
Cross-reactive and cross-neutralizing activity of human mumps antibodies against a novel mumps virus from bats. (27811320)
2016
17
Mumps Outbreak Among a Highly Vaccinated University Community-New York City, January-April 2014. (27927872)
2016
18
Mumps Virus Nucleoprotein Enhances Phosphorylation of the Phosphoprotein by Polo-Like Kinase 1. (26608325)
2016
19
Mumps Virus: Modification of the Identify-Isolate-Inform Tool for Frontline Healthcare Providers. (27625709)
2016
20
Vaccine-Preventable Diseases In Pediatric Patients: A Review Of Measles, Mumps, Rubella, And Varicella. (27893360)
2016
21
Challenges in interpreting diagnostic test results in a mumps outbreak in a highly vaccinated population. (28003216)
2016
22
Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015. (27449329)
2016
23
Molecular epidemiological study of mumps epidemics of 2015 in Okinawa, Japan. (28003601)
2016
24
Chronological changes of mumps virus genotypes in Japan between 1999-2013. (27206988)
2016
25
Measles-Mumps-Rubella vaccine for children with egg allergy: Is admission for inpatient vaccination necessary? (27770112)
2016
26
Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012. (27036176)
2016
27
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman. (27195163)
2016
28
Three cases of mumps virus and enterovirus coinfection in children with enteroviral meningitis. (27930588)
2016
29
Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University. (27424140)
2016
30
Aseptic meningitis after measles-mumps-rubella (MMR) vaccination. (27181175)
2016
31
Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand. (27138005)
2016
32
Releasing the genomic RNA sequestered in the mumps virus nucleocapsid. (27581981)
2016
33
High levels of susceptibility to measles, mumps and rubella (MMR) in HIV-infected individuals in Ireland. (27118245)
2016
34
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process. (27149048)
2016
35
Purification of mumps virus particles of high viability. (26992653)
2016
36
Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes. (26997012)
2016
37
Mumps, measles and rubella vaccination in children with PFAPA syndrome. (27997341)
2016
38
Mumps virus F gene and HN gene sequencing as a molecular tool to study mumps virus transmission. (27590714)
2016
39
Systematic review and meta-analysis of the association between mumps during childhood and risk of type 1 diabetes mellitus. (27658134)
2016
40
Recombinant mumps virus as a cancer therapeutic agent. (27556105)
2016
41
Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. (27488917)
2016
42
Iodide Mumps Complicating Coronary and Carotid Angiography. (27649884)
2016
43
Intralesional mumps, measles and rubella vaccine in the treatment of cutaneous warts. (27088951)
2016
44
Mumps in the Czech Republic in 2013: Clinical Characteristics, Mumps Virus Genotyping, and Epidemiological Links. (27070966)
2016
45
Estimating true hospital morbidity of complications associated with mumps outbreak, England, 2004/05. (27562958)
2016
46
Evidence of Mumps Infection Among Children in the Democratic Republic of Congo. (28002360)
2016
47
Still a pain in the neck after all this time: a case report of mumps in a previously immunized adult diagnosed in the ED. (27534433)
2016
48
Mumps virus pathogenesis: Insights and knowledge gaps. (27455055)
2016
49
Anesthesia mumps after thyroidectomy. (28000179)
2016
50
Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India. (26876221)
2016

Variations for Mumps

About this section

Expression for genes affiliated with Mumps

About this section
Search GEO for disease gene expression data for Mumps.

Pathways for genes affiliated with Mumps

About this section

Pathways related to Mumps according to GeneCards Suite gene sharing:

(show top 50)    (show all 69)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.7IL10RB, STAT1, STAT2
29.5HLA-DRB1, STAT1, STAT2
39.5IFNG, IL2, STAT1
4
Show member pathways
9.5IL2, IL2RA, STAT1
5
Show member pathways
9.4IFNG, IL12RB2, IL2RA
6
Show member pathways
9.3IFNG, STAT1, TNF
79.3IFNG, IRF2, STAT1, STAT2
89.3IFNG, IL2, TNF
99.3IFNG, IL2, TNF
109.3IFNG, IL2, TNF
119.3IFNG, IL10, IL2
129.2IL10, STAT1, TNF
139.2IFNAR2, STAT1, STAT2
149.1IL10, IL10RB, TNF
159.1IL10, IL10RB, TNF
16
Show member pathways
9.1IFNG, IL2, IL2RA, STAT1
179.1CD40LG, IFNG, IL2, IL2RA
189.1IFNG, IL10, TNF
199.1IFNG, IL10, TNF
20
Show member pathways
9.0CD40LG, HLA-DRB1, IL2, IL2RA
21
Show member pathways
9.0IL10RB, IL12RB2, IL2RA, STAT1, STAT2
22
Show member pathways
9.0CD40LG, IFNG, IL2, TNF
239.0IFNAR2, IFNG, IL2
248.9HLA-DRB1, IFNG, IL2, IL2RA
25
Show member pathways
8.9IFNAR2, IL10RB, STAT1, STAT2
268.9HLA-DPB1, HLA-DRB1, IL10
278.9CD40LG, IL10, IL2, TNF
28
Show member pathways
8.8IFNAR2, IFNG, STAT1, STAT2
298.8CD40LG, IFNG, IL10, TNF
308.8CD40LG, IL10, IL2RA, TNF
318.7IFNAR2, STAT1, STAT2, TNF
32
Show member pathways
8.6CD40LG, IFNG, IL2, IL2RA, TNF
338.6IFNG, IL10, IL12RB2, IL2, IL2RA
348.5HLA-DPB1, HLA-DRB1, IFNG, TNF
35
Show member pathways
8.5CD40LG, IFNG, IL10, IL2, TNF
368.5HLA-DPB1, HLA-DRB1, IL2RA, TNF
37
Show member pathways
8.4IFNAR2, IFNG, IL2, TNF
38
Show member pathways
8.4HLA-DRB1, IFNG, IL12RB2, IL2, IL2RA, STAT1
398.4IFNG, IL10, IL2, IRF2, TNF
408.3IFNG, IL10, IL2, IL2RA, TNF
41
Show member pathways
8.3IFNG, IL10, IL2, IL2RA, TNF
428.3IFNAR2, IFNG, STAT1, STAT2, TNF
438.3HLA-DRB1, IFNG, IL10, IL2, TNF
448.2HLA-DPB1, HLA-DRB1, IFNG, IL10, IL10RB
45
Show member pathways
8.2IFNG, IL10, IL10RB, IL2, STAT1, TNF
468.1HLA-DPB1, HLA-DRB1, IL2, IL2RA, TNF
478.1IFNG, IL10, IL12RB2, IL2, IL2RA, TNF
48
Show member pathways
8.0IFNAR2, IFNG, IL2, IL2RA, TNF
49
Show member pathways
8.0IFNG, IL10, IL12RB2, IL2, STAT1, STAT2
50
Show member pathways
7.9HLA-DRB1, IFNG, IL2, IL2RA, STAT1, STAT2

GO Terms for genes affiliated with Mumps

About this section

Cellular components related to Mumps according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:00426139.4HLA-DPB1, HLA-DRB1
2cell surfaceGO:00099868.5CD40LG, CD46, HLA-DPB1, HLA-DRB1, IL2RA, TNF
3external side of plasma membraneGO:00098978.5CD40LG, HLA-DRB1, IFNG, IL12RB2, IL2RA, TNF

Biological processes related to Mumps according to GeneCards Suite gene sharing:

(show all 38)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of regulatory T cell differentiationGO:004559110.6CD46, IL2
2positive regulation of isotype switching to IgG isotypesGO:004830410.5IFNG, IL2
3regulation of interferon-gamma-mediated signaling pathwayGO:006033410.5IFNG, STAT1
4negative regulation of lymphocyte proliferationGO:005067210.5IL2, IL2RA
5regulation of T cell homeostatic proliferationGO:004601310.4IL2, IL2RA
6inflammatory response to antigenic stimulusGO:000243710.3HLA-DRB1, IL2RA
7regulation of immunoglobulin secretionGO:005102310.3CD40LG, TNF
8positive regulation of calcidiol 1-monooxygenase activityGO:006055910.3IFNG, TNF
9positive regulation of chemokine biosynthetic processGO:004508010.3IFNG, TNF
10positive regulation of membrane protein ectodomain proteolysisGO:005104410.3IFNG, TNF
11positive regulation of MHC class II biosynthetic processGO:004534810.3IFNG, IL10
12positive regulation of vitamin D biosynthetic processGO:006055710.2IFNG, TNF
13endothelial cell apoptotic processGO:007257710.2IL10, TNF
14antigen processing and presentation of peptide or polysaccharide antigen via MHC class IIGO:000250410.2HLA-DPB1, HLA-DRB1
15negative regulation of cytokine secretion involved in immune responseGO:000274010.2IL10, TNF
16positive regulation of heterotypic cell-cell adhesionGO:003411610.2IL10, TNF
17positive regulation of vascular smooth muscle cell proliferationGO:190470710.1IL10, TNF
18receptor biosynthetic processGO:003280010.1IL10, TNF
19response to interferon-betaGO:003545610.0IFNAR2, STAT1
20negative regulation of inflammatory responseGO:00507289.9IL10, IL2, IL2RA
21JAK-STAT cascadeGO:00072599.9IFNAR2, STAT1, STAT2
22cellular response to lipopolysaccharideGO:00712229.8IFNG, IL10, TNF
23negative regulation of T cell proliferationGO:00421309.8HLA-DRB1, IL10, IL2RA
24antigen processing and presentationGO:00198829.8HLA-DPB1, HLA-DRB1, IFNG
25regulation of type I interferon-mediated signaling pathwayGO:00603389.8IFNAR2, STAT1, STAT2
26negative regulation of growth of symbiont in hostGO:00441309.8IFNG, IL10, TNF
27T cell costimulationGO:00312959.6CD40LG, HLA-DPB1, HLA-DRB1
28positive regulation of interferon-gamma productionGO:00327299.5HLA-DPB1, IL12RB2, IL2, TNF
29cell surface receptor signaling pathwayGO:00071669.4IFNAR2, IFNG, IL12RB2, IL2RA
30response to virusGO:00096159.3IFNAR2, IFNG, TNF
31defense response to virusGO:00516079.3IFNAR2, IFNG, IL10RB, STAT1, STAT2
32inflammatory responseGO:00069549.2CD40LG, IL10, IL10RB, IL2RA, TNF
33interferon-gamma-mediated signaling pathwayGO:00603339.2HLA-DPB1, HLA-DRB1, IFNG, IRF2, STAT1
34immune system processGO:00023769.1CD46, HLA-DPB1, HLA-DRB1, IL2, IL2RA
35positive regulation of T cell proliferationGO:00421028.9CD40LG, CD46, HLA-DPB1, IFNG, IL2, IL2RA
36type I interferon signaling pathwayGO:00603378.8IFNAR2, IRF2, STAT1, STAT2
37positive regulation of transcription from RNA polymerase II promoterGO:00459448.8IFNG, IL10, IL2, IRF2, STAT1, TNF
38immune responseGO:00069557.4CD40LG, HLA-DPB1, HLA-DRB1, IFNG, IL10, IL10RB

Molecular functions related to Mumps according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1tumor necrosis factor receptor bindingGO:00051649.5CD40LG, STAT1, TNF
2cytokine activityGO:00051258.9CD40LG, IFNG, IL10, IL2, TNF

Sources for Mumps

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet